Patents by Inventor Toni K. Choueiri

Toni K. Choueiri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GERMLINE BIOMARKERS OF CLINICAL RESPONSE AND BENEFIT TO IMMUNE CHECKPOINT INHIBITOR THERAPY
    Publication number: 20230374599
    Abstract: The present invention is based on the identification of novel metabolite biomarkers predictive of development of immune-related adverse events when receiving anti-immune checkpoint therapies.
    Type: Application
    Filed: October 18, 2021
    Publication date: November 23, 2023
    Inventors: Alexander Gusev, Toni K. Choueiri, Matthew Freedman
  • PBRM1 biomarkers predictive of anti-immune checkpoint response
    Patent number: 11377696
    Abstract: The present invention is based on the identification of novel biomarkers predictive of responsiveness to anti-immune checkpoint therapies.
    Type: Grant
    Filed: January 3, 2018
    Date of Patent: July 5, 2022
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Eliezer Van Allen, Diana Miao, Toni K. Choueiri
  • PBRM1 BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE
    Publication number: 20190338369
    Abstract: The present invention is based on the identification of novel biomarkers predictive of responsiveness to anti-immune checkpoint therapies.
    Type: Application
    Filed: January 3, 2018
    Publication date: November 7, 2019
    Inventors: Eliezer Van Allen, Diana Miao, Toni K. Choueiri